Bar Harbor BioTechnology raises first round
Bar Harbor BioTechnology, a Bar Harbor, Me., developer of DNA and RNA analysis equipment, raised a “multimillion dollar” first round of funding, VentureWire reports. The round was lead by Borealis Ventures, and also involved Village Ventures.
Bar Harbor Bio is a spinout of the Jackson Laboratory, a research institute known for its large collection of genetically engineered mice. The company is developing lab equipment and software for quantitative polymerase chain reaction, or qPCR — a method for identifying and measuring the prevalence of genes and their activity, or “expression.”
Next Story: Sonoma Orthopedics raises at least $10M for spinal devices
Previous Story: Interlace Medical, women's health company, picks up $5M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
